1. The Impact of Cannabidiol on the Induction of Isoflurane Anesthesia and Recovery in Wistar Rats
- Author
-
Tilen Vake, Matjaž Uršič, Alenka Babič, and Tomaž Snoj
- Subjects
Pharmacology ,Isoflurane ,business.industry ,digestive system ,digestive system diseases ,Rats ,surgical procedures, operative ,Complementary and alternative medicine ,Anesthesia ,Anesthesia Recovery Period ,medicine ,Sedative Effects ,Animals ,Cannabidiol ,Humans ,Pharmacology (medical) ,Premedication ,Rats, Wistar ,business ,medicine.drug ,Original Research - Abstract
BACKGROUND: Beside others, neuroinhibitory and sedative effects of CBD were documented. AIM AND METHODS: The aim of the study was to assess the dose-related effects of CBD premedication on the course of isoflurane anesthesia. Wistar rats were pretreated with different doses of CBD 1 h before isoflurane anesthesia. In the pretreatment, animals were given CBD at doses of 100, 20, 10, or 2 mg kg(−1). Before the fifth (control) anesthesia, the animals were given only mid-chain triglyceride oil, which served as a solvent in the CBD formulation. The induction time was determined, and on awakening, the time to appearance of the flexion reflex and the recovery from anesthesia were determined. RESULTS: Statistical analysis showed a significantly shorter induction time if animals were pretreated with 20 mg kg(−1) CBD. In addition, pretreatment with 100 mg kg(−1) CBD resulted in a prolonged induction time, while on awakening, delayed appearance of reflexes and prolonged recovery from anesthesia compared to pretreatment with 20 mg kg(−1) CBD were observed. CONCLUSIONS: The results indicate that the influence of CBD on the course of isoflurane anesthesia depends on the dose and can reduce the induction time. Although this study was performed in laboratory rats, in clinical practice, these data should be considered when CBD-treated patients undergo isoflurane anesthesia.
- Published
- 2023